Study Of Subjective Effect Of Stimol (Citrulline Malate) On Sexual Dysfunction In Multiple Sclerosis Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016090629725N1

Enrollment

Registered

2017-04-11

Start date

2017-05-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sexual Dysfunction. Unspecified Sexual Dysfunction, not Caused by Organic Disorder or Disease

Interventions

25 Patients: Placebo For 30 Days

Intervention 1: 25 Patients: Oral Solution Stimol 3 gr per Day For 30 Days. Intervention 2: 25 Patients: Placebo For 30 Days.

Treatment - Drugs

Placebo

25 Patients: Oral Solution Stimol 3 gr per Day For 30 Days

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: inclusion criteria: Patients with multiple sclerosis who have sexual dysfunction; Not using stimol currently. exclusion criteria: Anatomical sexual dysfunction; Use libido booster drugs; Pregnancy and breast feeding.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Sexual dysfunction in MS patients. Timepoint: First Day and One Month Later. Method of measurement: IIEF-5 Standard Questionnaire for Men and FSFI Standard Questionnaire for women.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKoorosh Kamali

Zanjan University of Medical Sciences

drkamali@zums.ac.ir+98 24 3378 1300

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026